Scientific Advisor

Professor Samuel Samnick is the Head of the Interdisciplinary PET Centre and Radiopharmacy at the Department of Nuclear Medicine of the University Würzburg (Germany). Upon completion of an engineering degree (1988) at the University of Applied Sciences Nuremberg, he obtained his Diploma in Bio-organic chemistry at the University of Osnabrück (1991), and a PhD on the development and validation of specific radiotracers for addressing receptors in neurological diseases using PET and SPECT (1994) at the Department of Nuclear Medicine of the University Münster, Germany. He pursued his post-doctoral studies (1994-1997) at the Centre for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen/Zurich, Switzerland, and at the Ludwig Institute for Cancer Research, Melbourne, Australia. In 1997 he joined the Department of Nuclear Medicine at the University of Saarlandes (Germany) as head of the radiopharmaceutical research and accomplished his habilitation (2001) in Experimental Nuclear Medicine and Radiopharmaceutical Chemistry, followed by an appointment as Assistant Professor in Radiopharmaceutical Sciences (2001) and as Apl. Professor (2005) at the University Medical School, Homburg/Saar (Germany). In 2007, he was appointed as Full Professor for Experimental Nuclear Medicine and Radiopharmacy and Head of the Interdisciplinary PET-Centre at the Julius-Maximilians University Würzburg (Germany).